Study Title and Description
Randomized trial of Alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation.
Key Questions Addressed
|3||In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?|
Primary Publication Information
|Title||Randomized trial of Alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation.|
|Author||Vathsala A., Ona ET., Tan SY., Suresh S., Lou HX., Casasola CB., Wong HC., Machin D., Chiang GS., Danguilan RA., Calne R.|
|Country||Department of Renal Medicine, Singapore General Hospital, Singapore. firstname.lastname@example.org|
Pubmed ID: 16210963
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Comparative Effectiveness of Regimens
Results & Comparisons
No Results found.